The following is a list of the side effects reported to be possibly related to the injection procedure or to the medicine. As with all therapeutic proteins, there is a possibility for an immune reaction (formation of antibodies) with Eylea. Patients with DME will be treated with one injection per month for the first five consecutive doses followed by one injection every two months thereafter. The other ingredients are: polysorbate 20 (E 432), sodium dihydrogen phosphate monohydrate (for pH adjustment), disodium hydrogen phosphate heptahydrate (for pH adjustment), sodium chloride, sucrose, water for injections.

Women of childbearing potential have to use effective contraception during treatment and for at least three further months after the last injection of Eylea. Using aseptic technique withdraw all of the Eylea vial contents into the syringe, keeping the vial in an upright position, slightly inclined to ease complete withdrawal.The use of Eylea in children or adolescents under 18 has not been studied because wet AMD, CRVO, BRVO, DME and myopic CNV occur mainly in adults.

injections with Eylea may cause an increase in eye pressure (intraocular pressure) in some patients within 60 minutes of the injection. Eyelead, Optical Quality Products, αποτελεί μάρκα (brand) της ελληνικής εταιρίας VITORGAN με γυαλιά πρεσβυωπίας και ηλίου για παιδιά και ενήλικες. Allergic reactions like rash, itching (pruritus), hives (urticaria), and a few cases of severe allergy (anaphylactic/a­naphylactoid) reactions were reported. your doctor will check whether you have other risk factors that may increase the chance of a tear or detachment of one of the layers at the back of the eye (retinal detachment or tear, and retinal pigment epithelial detachment or tear), in which case Eylea must be given with caution.In the clinical trials, there was an increased incidence of bleeding from small blood vessels in the outer layers of the eye (conjunctival haemorrhage) in patients with wet AMD receiving blood thinners. Eylea should not be used in pregnancy unless the potential benefit outweighs the potential risk to the unborn child. Some of these may be serious and include blindness , a serious infection or inflammation inside the eye (endophthalmitis), detachment, tear or bleeding of the light-sensitive layer at the back of the eye (retinal detachment or tear), clouding of the lens (cataract), bleeding in the eye (vitreous haemorrhage), detachment of the gel-like substance inside the eye from the retina (vitreous detachment) and increase of pressure inside the eye , see section 2.

Eyelead με polarized φακούς κατηγορίας 3 εξαιτίας του αποκλεισμού της διέλευσης των κατά 90 μοιρών οριζόντια πολωμένων ακτίνων του φωτός προς το μάτι, έχουν την ικανότητα να εμποδίζουν την αντανάκλαση του έντονου φωτός (ποσοστό απορρόφησης 82-92%) και να προσφέρουν στον χρήστη βελτιωμένη όραση. Your doctor may decide to stop treatment with Eylea if it is determined that you are not benefiting from continued treatment. Using aseptic technique, firmly twist a30 G x There are limited data on safety in treating patients with CRVO, BRVO, DME and myopic CNV who have had a stroke or a mini-stroke (transient ischaemic attack) or a heart attack within the last 6 months. The systemic use of VEGF inhibitors, substances similar to those contained in Eylea, is potentially related to the risk of blood clots blocking blood vessels (arterial thromboembolic events) which may lead to heart attack or stroke. Eliminate all bubbles and expel excess medicinal product by slowly depressing the plunger to align the base of the plunger dome (not the tip of the dome) with the black dosing line on the syringe (equivalent to 0.

In patients with wet AMD and myopic CNV, these factors, in excess are involved in the abnormal formation of new blood vessels in the eye. Eylea has been shown to stop the growth of new abnormal blood vessels in the eye which often leak fluid or bleed.Your doctor will then decide whether the treatment interval between injections may be kept at every two months or be gradually extended in 2– or 4-weekly intervals if your condition has been stable.